PROTAC CDK2/9 Degrader-1 is a dual degrader that effectively targets CDK2 and CDK9 by linking a CDK inhibitor with a Cereblon ligand. This compound disrupts cell cycle progression in the S and G2/M phases, thereby inhibiting the proliferation of prostate cancer cells.
Usually ships within 24 hours.